Tirzepatide, a innovative medication, is sparking significant buzz in the healthcare community as a possible treatment for both type 2 diabetes and body composition . This dual-action drug works by targeting two distinct receptors, GLP-1 and GIP, leading to enhanced glycemic management and significant fat loss in clinical trials . While preliminary